Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value
$315.63M
Total Bought
$63.81M
Total Sold
$39.89M
Net Transaction
+$23.91M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
RHYTHM PHARMACEUTICALS INC(RYTM)763,707992,200+228,49377,127106,20533.65%+29,078
ARGENX SE(ARGX)150,000142,000-8,000110,634119,41537.83%+8,781
CYTOKINETICS INC(CYTK)37,587166,823+129,2362,06610,6003.36%+8,534
DISC MEDICINE INC(IRON)430,000452,992+22,99228,41435,97211.40%+7,558
REVOLUTION MEDICINES INC(RVMD)492,300370,000-122,30022,99029,4719.34%+6,480
KYMERA THERAPEUTICS INC(KYMR)61,7500-61,7503,4950—-3,495
STOKE THERAPEUTICS INC(STOK)212,0490-212,0494,9830—-4,983
SEPTERNA INC(SEPN)283,1580-283,1585,3260—-5,326
CRINETICS PHARMACEUTICALS IN(CRNX)260,0000-260,00010,8290—-10,829
CORCEPT THERAPEUTICS INC(CORT)392,331401,395+9,06432,60713,9694.43%-18,638
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q4 2025 | TickerTrail